BUZZ-Hims & Hers Health shares fall after the company lowered its 2026 revenue forecast
路透社2026/11/09 21:36November 9 - ** The health and wellness platform Hims & Hers Health (HIMS.N) saw its stock price fall 2.3% to close at $22.46 in after-hours trading
** The company lowered its annual revenue forecast (link) to a range below Wall Street expectations, as its expansion into branded weight-loss drugs and international markets led to a narrowing of its gross margin
** The company now expects 2026 revenue to be between $3.13 billion and $3.15 billion, compared to a previous forecast of $3.10 billion to $3.30 billion
** According to data compiled by London Stock Exchange Group (LSEG), analysts had expected $3.21 billion
** HIMS reported third-quarter revenue of $890.4 million, missing expectations of $892.9 million
** As of the close of the previous trading day, HIMS is down 29.3% year-to-date
(For the convenience of non-English speakers, Reuters has automated the translation of its reports into several other languages. As automated translation may contain errors or may not provide the required context, Reuters does not guarantee the accuracy of automated translations and provides them for readers’ convenience only. Reuters accepts no liability for any damage or loss caused by the use of automated translation features.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Japanese dovish policymaker urges "slow down": Price increases are not driven by demand, rate hikes may drag down the economy and inflation
Toichiro Asada, a member of the Bank of Japan's Policy Board, stated that the central bank needs to remain cautious and closely monitor the impact of rate hikes on the economy, as rising interest rates pose the risk of suppressing the inflation trend.
Don't Be Misled by "Instant Purchase, Instant Access": Pro Series Zero Wait Has Been the Norm for Years, UBS Maintains Apple (AAPL.US) Target Price at $340
The waiting time for iPhone 18 Pro is approaching zero, and Duo deliveries are scheduled until the end of January. UBS maintains its forecast for iPhone revenue in the December quarter at $95.1 billions, representing a year-on-year increase of 11.5%.
Nvidia's "black swan" shakes up AI faith! Jensen Huang's controversy draws in U.S. Treasury bond buying, long-term U.S. Treasuries rise against the trend
After a brief holiday break, the US Treasury market has resumed trading, with long-term US Treasury prices rising slightly. The recent turmoil surrounding Nvidia has caused doubts about the main AI trading narrative, prompting safe-haven buying into US Treasuries.
Crypto prices
More
